Eli Lilly and JDRF to fund research into beta cell regeneration
17/02/2011
No Comments
Eli Lilly and Company (NYSE: LLY) and the Juvenile Diabetes Research Foundation (JDRF) announced in early February 2011 that they have signed an agreement to
